Precision brain zapping: new hope for stubborn depression?
NCT ID NCT07287839
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new method of delivering repetitive transcranial magnetic stimulation (rTMS) for people with treatment-resistant depression. Instead of the standard approach, the new method uses brain surface mapping to target a specific area. The trial will compare the two methods in 60 adults to see if the new targeting improves depression symptoms.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TREATMENT RESISTANT DEPRESSION (TRD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can magnetic brain stimulation keep depression at bay longer than a drug?
- One-Day brain zaps: a new hope for stubborn depression?
- Can the immune system hold the key to treating resistant mental illness?
- Could group talk boost the benefits of psychedelic therapy for depression?
- Could CBD oil lift the fog of Treatment-Resistant depression?
- Which works best for stubborn depression? adding a drug, brain stimulation, or switching meds?